MA23587A1 - TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME - Google Patents

TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Info

Publication number
MA23587A1
MA23587A1 MA23930A MA23930A MA23587A1 MA 23587 A1 MA23587 A1 MA 23587A1 MA 23930 A MA23930 A MA 23930A MA 23930 A MA23930 A MA 23930A MA 23587 A1 MA23587 A1 MA 23587A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
treatment
need
related syndrome
Prior art date
Application number
MA23930A
Other languages
French (fr)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23587A1 publication Critical patent/MA23587A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA23930A 1994-06-23 1995-05-16 TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME MA23587A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23587A1 true MA23587A1 (en) 1995-12-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23930A MA23587A1 (en) 1994-06-23 1995-05-16 TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Country Status (6)

Country Link
AU (1) AU2770895A (en)
IL (1) IL114128A0 (en)
MA (1) MA23587A1 (en)
PE (1) PE41096A1 (en)
WO (1) WO1996000070A1 (en)
ZA (1) ZA955031B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033581A1 (en) * 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
DK0906089T3 (en) * 1996-05-13 2003-12-08 Novartis Consumer Health Sa The buccal delivery system
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
JP2003509455A (en) 1999-04-06 2003-03-11 ダブリューエム リグリー ジュニア カンパニー Pharmaceutical chewing gum formulation
DE20018196U1 (en) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Confectionery product for smoking cessation
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
CA2526475A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2012083947A1 (en) * 2010-12-21 2012-06-28 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
US20230320406A1 (en) * 2020-09-03 2023-10-12 Nicoventures Trading Limited Compositions and methods
CN115590855A (en) * 2022-10-26 2023-01-13 江南大学（Cn） Method for reducing nicotine content in nicotine product

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (en) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Manufacture of solid drug forms with delayed release of active ingredients
DE1901277A1 (en) * 1969-01-10 1970-08-06 Partipharm Ag Chewing gum to com ensate for excessive - cigarette smoking
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (en) * 1989-07-24 1989-07-24 Fertin Lab As ANTIFUNGAL CHEMICAL GUM PREPARATION
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526A (en) * 1990-08-23 1992-02-24 Wrigley W M Jun Co TUGGUMMI MED LAOG FUKTHALT.

Also Published As

Publication number Publication date
IL114128A0 (en) 1995-10-31
PE41096A1 (en) 1996-10-08
WO1996000070A1 (en) 1996-01-04
ZA955031B (en) 1996-02-08
AU2770895A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
MA23587A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
DE69619433D1 (en) Tobacco smoke filters and methods of making the same
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
FI950587A0 (en) Methods useful in the prevention and treatment of endotoxin poisoning
PT836390E (en) CIGARETTE AND METHOD FOR THE MANUFACTURE OF CIGARETTE FOR ELECTRICAL SYSTEM OF SMOKING
FR2726191B1 (en) DEVICE FOR THE TREATMENT OF APNEA SYNDROME DURING SLEEP
DE69520816D1 (en) Tobacco smoke filter material and tobacco smoke filter made from this material
NO992641D0 (en) Mixtures and Methods for the Treatment or Prevention of Inflammatory Diseases
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
DE69626920D1 (en) Tobacco smoke filter material and tobacco smoke filter made from this material
DE69003977D1 (en) Method and device for determining the stem content of tobacco.
DE69501493D1 (en) Removal of moisture and passivation of surfaces
FI956339A (en) Treatment of absence of hypothalamic menstruation
EE9800234A (en) Method of treatment and pharmaceutical composition
NO951175D0 (en) Cigarette filter and process for its manufacture
ATE201992T1 (en) CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
MA23588A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
DE69306328D1 (en) Device for automatic smoking of tobacco rolls and for analyzing the smoke
MA23586A1 (en) TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
BR9001661A (en) SMOKING AND TOBACCO TREATMENT ARTICLE
ITMI931359A1 (en) PROCEDURE AND DEVICE FOR DRYING TOBACCO
FI972055A (en) Procedure of analysis of saliva
BR9507375A (en) Treatment of particulate surfaces
MD654F1 (en) Tobacco processing process Process of tobacco treatment
FR2748907B3 (en) USE OF WALES AND GALLIC DERIVATIVES IN THE MANUFACTURE OF CIGARETTES AND THE TREATMENT OF TOBACCO